Photo: Mufid Majnun
The US government aims to launch COVID-19 shots for children aged under 5 to be on February 21, said a document from the US Centers for Disease Control and Prevention.
While Pfizer Inc and BioNTech did not measure up to a fundamental target in a clinical trial of 2–4-year-olds, the US Food and Drug Administration (FDA) is thinking of legally permitting the use of these vaccines in the age group.
The drug manufacturers stated that they put forward a date supporting legal permission at FDA’s request for the sake of addressing a critical public health necessity in the age group.
FDA exterior advisers are set to meet on February 15 to talk about whether they would suggest for the agency to legally permit the vaccine. The launch of the shots for children aged under 5 is scheduled to start under a week following the meeting.
The US government is aiming to import 10 million doses of the Pfizer/BioNTech vaccine, initially, to states and other facilities prior to the end of February, according to the CDC document, should the FDA permit their use.
In the United States, there are around 18 million children between the ages of 6 months and 4 years, and there will be more supply past the primary 10 million doses, said the CDC.
The first launch will start with areas where there is a higher risk for critical COVID-19 disease for children.
The second and third shipment of doses will be given to jurisdictions and federal pharmacy partners on February 23 and February 25 or around a week following the CDC advisory.
If it is permitted, children as young as the age group will get a lower dose of the vaccine. Pfizer/BioNTech tried out 3 micrograms of the vaccine in the age group, while 10-microgram does in the 5–11-year-olds and 30-microgram dose for individuals aged 12 and older.
Opinions expressed by Artist Weekly contributors are their own.